Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in a context-dependent manner (Q42207794)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 July 2014

Language	Label	Description	Also known as
English	Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in a context-dependent manner	scientific article published on 5 July 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in a context-dependent manner (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

author name string

Shilpa Patil

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ipsita Choudhary

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Nakul K Chaudhary

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Rajesh Ringe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Manish Bansal

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Brihaspati Narayan Shukla

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jayanta Bhattacharya

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

0 references

publication date

5 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

462-463

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

266-272

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24999839%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Molecular architecture of native HIV-1 gp120 trimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

The cat and mouse of HIV-1 antibody escape

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

The role of antibodies in HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

The Antibody Response against HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Subtle alteration of residues including N-linked glycans in V2 loop modulate HIV-1 neutralization by PG9 and PG16 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Naturally occurring substitutions of conserved residues in human immunodeficiency virus type 1 variants of different clades are involved in PG9 and PG16 resistance to neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Broad neutralization coverage of HIV by multiple highly potent antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Structural definition of a conserved neutralization epitope on HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42207794&oldid=1935970949"